FIELD: medicine, hepatology, pharmacy. SUBSTANCE: invention relates to the development of hepatoprotecting agent. The agent is made as injection solution and comprises essential phospholipids, benzyl alcohol, dihydroxycholic acid, sodium chloride, sodium hydroxide, riboflavin, α-tocopherol, ethanol and injection water taken in the definite ratio of components. Agent is non-toxic and devoid significant alterations in enzymes activity, hemoglobin level, amount of platelets and leukocytes in administration. EFFECT: valuable medicinal properties of agent. 3 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING LIVER DISEASES | 2019 |
|
RU2725622C1 |
INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
THERAPEUTIC AGENT FOR PREVENTING AND TREATING CHRONIC LIVER DISEASES | 2012 |
|
RU2526172C2 |
COMPOSITION FOR INJECTION BASED ON PHOSPHOTIDYLCHOLINE, METHIONINE, VITAMIN E AND SODIUM SELENITE - "HEPARS", WHICH HAS HEPATOPROTECTIVE PROPERTIES, AND A METHOD FOR ITS PREPARATION | 2020 |
|
RU2760685C1 |
METHOD FOR CORRECTION OF ISONIAZID-INDUCED HEPATOTOXIC REACTIONS | 2015 |
|
RU2601919C1 |
COMPOSITION WITH HEPATOPROTECTIVE AND METABOLISM NORMALIZING ACTIVITY | 2005 |
|
RU2283114C1 |
PHARMACEUTICAL COMPOSITION ELICITING HEPATOPROTECTIVE EFFECT AND MEDICINAL AGENT | 2003 |
|
RU2257208C1 |
HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
METHOD OF PREVENTING CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2363456C1 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
Authors
Dates
2004-03-20—Published
2003-03-04—Filed